[MU-BIS(DIALKYLPHOSPHINO)ALKANE]-BIS[PENTACARBONYLMETAL(0)] COMPLEXES OF THE GROUP-6B ELEMENTS - SYNTHESIS AND SPECTROSCOPIC STUDY

[mu-Bis(dialkylphosphino)alkane]-bis[pentacarbonylmetal(0)] complexes (CO)5MR2P(CH2)nPR2M(CO)5, (M: Cr, Mo, W; n: 1, 2, 3; R: CH3, C2H5, C6H5) were synthesized from the reaction of M(CO)5(CH3CN) with the appropriate ligand and characterized by means of IR and NMR (H-1, C-13, P-31) spectroscopy. Spectral data indicate that the complexes contain two identical M(CO)5 moieties linked to each other by the R2P(CH2)nPR2 ligand. Each metal atom has a pseudo-octahedral arrangement of the five CO ligands and one phosphorus atom

Investigation of RASSF4 gene in head and neck cancers

Objectives RASSF gene family can inhibit the growth of RAS oncogene. This gene family is suggested to have a role in cell cycle control, apoptosis, cell migration, and mitosis control. This study evaluated RASSF4 gene expression levels, SNPs and serum levels in tissues dissected from both healthy individuals and patients diagnosed with head, and neck cancer. Methods RASSF4 gene expression levels were determined using the RT-PCR. Serum levels of RASSF4 were tested using the Enzyme-Linked Immuno Sorbent Assay technique in study groups. RASSF4 rs7896801 and rs884879 genotypes were identified using by the RT-PCR. Results No statistical difference was observed between study groups according to RASSF4 gene expression levels. According to SNP results, rs7896801 revealed a 2.4 fold increase of G-allele presence in patients (p=0.015). The increase in the presence of AA genotype was statistically significant for the control group (p=0.015). Distribution of genotypes and alleles for rs884879 showed a 2.2 fold increase in CC genotype for healthy group (p=0.031) however, the presence of T allele showed a significant increase in the patients (p=0.048). Conclusions We suggest that this study will play a pioneering role for the next studies on RASSF4 gene, especially on SNPs

Evaluation of the factors affecting the necessity for revision surgery in choanal atresia.

Objective: This study aims to compare the effects of different surgical techniques for congenital choanal atresia (CCA), and particular emphasis is given to the analysis of the factors affecting the surgical outcome. The necessity for revision surgery and surgical outcomes were retrospectively investigated in patients undergoing revision surgery according to a recently proposed classification system. Material and method: A retrospective study was conducted on patients operated for CCA between January 2007 and December 2018 at a university hospital. Data in the medical records, including patient age when the initial surgery was performed, gender, additional anomalies and medical conditions, the duration of gestation, side and type of atresia, type of surgery and need for revision surgery were reviewed. Results: Forty-five patients treated for CCA in our university hospital were screened. The mean follow-up duration was 82.16 months. Revision surgery was required in 9 of 26 cases, which are included in the study (34.6%). Fourteen patients presented with bilateral CCA, while 12 were unilateral cases. Sixteen patients (61.5%) had comorbid medical conditions. While the removal of vomer and mucoperiosteal flap use affects successful surgical repair, no differences were observed in choanal atresia type, laterality, use of stent and the presence of additional medical conditions. Conclusion: The most important factors affecting surgical success for CCA are the removal of the vomer and closure of all bare bone tissues using a mucoperiosteal flap. Use of stents provides no additional benefit, apart from preventing synechiae formation